Lucide Ledger

A filing-first public record from Lucide House.

Issue 002 | U.S. Pilot | US

HOOK

HOOKIPA Pharma Inc.

Screen state: Needs Review Source state: Stale Filing 10-Q | 2025-05-15 Filing currency: USD
Open Filing Back to Register Report a correction
Internal NCAV Discount 56.2%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
60,091,000USD
Total Liabilities
27,176,000USD
NCAV
32,915,000USD
Cash
40,276,000USD
NCAV per share
2.62USD/share
Evidence
6 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 10.0 on 2024-07-09

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Medium | Filing

Some rows are based on older filing data and require manual freshness review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
Revenue 43,946,000 20,129,000 14,249,000 18,448,000 19,584,000 11,942,000
Operating Income -51,455,000 -97,694,000 -73,155,000 -81,674,000 -53,285,000 -51,085,000
Net Income -43,503,000 -81,580,000 -64,915,000 -75,665,000 -44,082,000 -43,037,000
Cash From Operations -76,978,000 -57,524,000 -19,997,000 -66,016,000 -39,339,000 -41,731,000
Capex -194,000 -4,159,000 -5,017,000 -12,581,000 -2,371,000 -1,999,000
Free Cash Flow -77,172,000 -61,683,000 -25,014,000 -78,597,000 -41,710,000 -43,730,000
Cash And Equivalents 39,684,000 117,096,000 112,488,000 65,921,000 142,743,000 113,151,000
Accounts Receivable 290,000 511,000 6,533,000 6,895,000 5,542,000 1,537,000
Inventory n/a n/a n/a n/a n/a n/a
Total Current Assets 80,665,000 147,116,000 147,196,000 102,135,000 171,504,000 128,017,000
Total Assets 82,545,000 161,337,000 170,454,000 126,045,000 187,817,000 143,745,000
Total Current Liabilities 24,653,000 41,988,000 35,632,000 27,654,000 21,143,000 14,755,000
Total Liabilities 31,331,000 71,480,000 67,937,000 36,453,000 31,694,000 25,846,000
Shareholders Equity 51,214,000 89,857,000 102,517,000 89,592,000 156,123,000 117,899,000
Shares Outstanding 12,054,539 98,950,107 54,716,655 31,203,215 29,771,422 25,566,124
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 12,538,794 94,526,561 65,512,957 32,833,590 26,039,108 17,859,935
Weighted Avg Shares Basic 12,538,794 94,526,561 65,512,957 32,833,590 26,039,108 17,859,935
Net Share Count Change (Normalized) 0.0% 17.9% 0.0% 4.3% 16.4% Insufficient evidence
Ownership Claim Change (Normalized) 0.0% -15.2% 0.0% -4.2% -14.1% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
2021-03-31
10-Q
USD
2020-12-31
10-K
USD
2020-09-30
10-Q
USD
2020-06-30
10-Q
USD
Revenue 2,004,000 1,354,000 4,703,000 1,290,000 36,599,000 7,407,000 6,867,000 2,679,000 3,176,000 7,828,000 2,230,000 2,746,000 1,445,000 3,895,000 3,874,000 5,378,000 5,301,000 5,163,000 4,040,000 6,685,000
Operating Income -17,874,000 -21,459,000 -18,644,000 -22,458,000 11,106,000 -30,895,000 -22,670,000 -21,472,000 -22,657,000 -13,588,000 -20,993,000 -18,427,000 -20,147,000 -22,047,000 -21,166,000 -19,289,000 -19,172,000 -15,194,000 -16,406,000 -9,226,000
Net Income -15,427,000 -24,950,000 -13,841,000 -19,095,000 14,383,000 -24,818,000 -19,066,000 -18,016,000 -19,680,000 -12,311,000 -18,280,000 -16,356,000 -17,968,000 -21,234,000 -20,040,000 -17,153,000 -17,238,000 -12,475,000 -13,589,000 -7,092,000
Cash From Operations 52,000 -20,938,000 -17,508,000 -14,376,000 -24,156,000 -11,224,000 -24,119,000 -19,333,000 -2,848,000 13,137,000 -16,508,000 -18,359,000 1,733,000 -13,243,000 -17,644,000 -20,732,000 -14,397,000 -11,301,000 -10,365,000 -10,545,000
Capex -20,000 -2,000 -31,000 -45,000 -116,000 -422,000 -3,018,000 -445,000 -274,000 -599,000 -958,000 -1,632,000 -1,828,000 -5,141,000 -2,486,000 -4,624,000 -330,000 -505,000 -625,000 -1,042,000
Free Cash Flow 32,000 -20,940,000 -17,539,000 -14,421,000 -24,272,000 -11,646,000 -27,137,000 -19,778,000 -3,122,000 12,538,000 -17,466,000 -19,991,000 -95,000 -18,384,000 -20,130,000 -25,356,000 -14,727,000 -11,806,000 -10,990,000 -11,587,000
Cash And Equivalents 40,276,000 39,684,000 59,750,000 77,150,000 92,751,000 117,096,000 107,676,000 135,587,000 109,600,000 112,488,000 99,776,000 117,918,000 140,825,000 65,921,000 82,269,000 102,523,000 127,716,000 142,743,000 81,830,000 92,857,000
Total Current Assets 60,091,000 80,665,000 93,156,000 107,351,000 132,710,000 147,116,000 139,471,000 168,143,000 139,913,000 147,196,000 129,611,000 149,077,000 171,079,000 102,135,000 118,577,000 143,451,000 153,340,000 171,504,000 105,795,000 117,893,000
Total Liabilities 27,176,000 31,331,000 37,928,000 38,982,000 41,349,000 71,480,000 68,959,000 78,780,000 79,609,000 67,937,000 38,178,000 40,258,000 47,782,000 36,453,000 34,086,000 40,222,000 29,886,000 31,694,000 29,092,000 29,353,000
Shares Outstanding n/a 12,054,539 12,054,539 12,054,539 98,950,107 12,054,539 83,950,107 83,950,107 54,722,339 54,716,655 54,716,655 54,704,528 54,692,466 31,203,215 29,903,797 29,871,578 n/a 29,768,444 n/a n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 12,544,777 12,538,794 12,538,774 12,538,774 125,976,054 112,181,585 110,388,107 82,705,264 72,217,823 72,213,657 72,230,709 72,195,007 45,040,022 32,887,599 32,874,426 32,804,269 32,766,284 27,210,402 25,659,504 25,647,819
Weighted Avg Shares Basic 12,544,777 12,538,794 12,538,774 12,538,774 125,388,107 112,181,585 110,388,107 82,705,264 72,217,823 72,213,657 72,230,709 72,195,007 45,040,022 32,887,599 32,874,426 32,804,269 32,766,284 27,210,402 25,659,504 25,647,819
Net Share Count Change (Normalized) Insufficient evidence 0.0% 0.0% 21.8% 0.0% 17.9% 0.0% 53.4% 0.0% 0.0% 0.0% 0.0% 75.3% 4.3% 0.1% 0.3% Insufficient evidence 16.4% Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence 0.0% 0.0% -17.9% 0.0% -15.2% 0.0% -34.8% -0.0% 0.0% -0.0% -0.0% -42.9% -4.2% -0.1% -0.3% Insufficient evidence -14.1% Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 60,091,000USD us-gaap:AssetsCurrent 2025-03-31 1.00 Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Total Liabilities 27,176,000USD us-gaap:Liabilities 2025-03-31 1.00 Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Cash 40,276,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2025-03-31 1.00 Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Shares Outstanding 12,544,777 us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 2025-03-31 1.00 Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
NCAV 32,915,000USD derived 2025-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.62USD derived 2025-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 56.2% derived 2025-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001760542
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001760542/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
22
Imported At
2026-08-15T12:52:11+00:00
Rendered At
2026-08-16T03:29:43+00:00

Run Audit

Mary Run
f75c5d221f074da8a489fba328e8ef51
Mary As Of
2026-07-18
Accession
0001558370-25-007871
CIK
0001760542
Mary Filing Date
2025-05-15
Filing Currency
USD
Internal Discount
56.2%
Source State
Stale Filing
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=f75c5d221f074da8a489fba328e8ef51; mary_as_of=2026-07-18; mary_filing_date=2025-05-15; mary_accession=0001558370-25-007871; mary_cik=0001760542; gnni_supporting_filing_date=2025-05-15; internal_discount=0.561705; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review

Back to Register Report a correction Archive